Margaretta Page

Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Michael D. Prados, Susan M. Chang, Nicholas Butowski et al. · Journal of Clinical Oncology · 2008 · 371 citations · Full text

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

Susan M. Chang, Kathleen R. Lamborn, Mary Malec et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 138 citations · Full text

Neuro-oncology, Radiation Medicine, Radiation Therapy +9

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

Michael D. Prados, William M. Wara, Penny K. Sneed et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 135 citations

Neuro-oncology, Radiation Therapy, Accelerated Hyperfractionation +10

Temozolomide in the treatment of recurrent malignant glioma

Susan M. Chang, Philip V. Theodosopoulos, Kathleen R. Lamborn et al. · Cancer · 2004 · 89 citations · Full text

Quality of life in low-grade glioma patients receiving temozolomide

Raymond Liu, Karla Solheim, Mei‐Yin C. Polley et al. · Neuro-Oncology · 2008 · 88 citations · Full text

Neuro-oncology, Quality Of Life, Low-grade Glioma Patients +14